Immunodiagnosis of Human Toxocariasis by William H. Roldán & Guita Rubinsky-Elefant
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
7 
Immunodiagnosis of Human Toxocariasis 
William H. Roldán1 and Guita Rubinsky-Elefant2 
1Instituto de Medicina Tropical ‘Daniel A. Carrión’,  
Universidad Nacional Mayor de San Marcos, Lima-Perú, 
 2Instituto de Medicina Tropical de São Paulo, 
 Universidade de São Paulo, SP,  
Brasil 
1. Introduction 
Human toxocariasis is a helminthic zoonosis caused by larval stages of Toxocara canis and, 
less frequently, by T. cati, the roundworms of dogs and cats, respectively. Accidentally, 
humans ingest embryonated eggs containing the infective larva which are released in the 
upper small intestine and then pass through the intestinal epithelium to reach the blood 
vessels, where they can migrate to the different visceral organs and tissues of the body 
(Despommier, 2003). 
An interesting phenomenon is that these parasites cannot develop into adult forms in 
humans and are restricted to larval forms, migrating through the soft tissues for months and 
even years and causing local or systemic inflammatory reactions in the affected organ. 
Sometimes the immune system can even kill the parasite, however, the immunity generated 
with the first infection fails to protect against future reinfections. It has been reported that 
the larvae can survive for many years and even decades in the human host, causing local 
tissue necrosis, eosinophilic inflammatory reactions and granuloma formation (Schantz & 
Glickman, 1978; ; Minvielle et al., 1999; Magnaval et al., 2001; Despommier, 2003). 
The spectrum of the clinical manifestations in human toxocariasis varies widely from 
asymptomatic cases to systemic infections. Clinical manifestations and the course of the 
disease will be determined by the inoculum, the frequency of reinfection episodes in the 
patient, the location of migrating larvae in the affected organ, and the host response 
(Pawlowski, 2001). 
However, both the inoculum and the frequency of reinfection episodes cannot be measured 
directly in humans, but they can be assumed through the frequency of contaminated 
environments with Toxocara spp. eggs or by the proportion of children with habits of 
geophagy in the area or region studied (Magnaval et al., 2001; Pawlowski, 2001; Smith et al., 
2009). Migrating larvae may be identified by means of clinical examination and the use of 
diagnostic imaging tests in order to looking for granulomas, either in the eye, brain or liver 
(Despommier, 2003). Even when it cannot be directly observed, the imaging diagnostics 
proves to be of aid to suspect the causative agent; however, all clinical suspicion should be 
confirmed by additional laboratorial tests (Chieffi et al., 2009; Rubinsky-Elefant et al., 2010), 
as discussed below. 
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2. Toxocara and toxocariasis in humans 
Toxocariasis is more probable in tropical and subtropical areas and it is considered of higher 
risk in populations from both periurban and rural areas with poor sanitation, and where the 
people do not usually deworm their pets (Glickman & Schantz, 1981). However, this concept 
has been reversed as there are confirmed cases of toxocariasis in people who have never had 
dogs at home, which has led to an awareness of the environmental contamination with 
parasitized dog feces, especially in public parks, children playgrounds and streets (Holland 
et al., 1991; Uga et al., 1996; Habluetzel et al., 2003; Avcioglu & Balkaya, 2011). 
Adult stages of Toxocara canis and T. cati have their habitat in the small intestine of their 
definitive hosts: the canines and felines. The adult gravid female of the parasites release 
their eggs in the intestinal lumen, which are then released outside with the feces. Toxocara 
eggs are not immediately infective. The larval development inside the egg varies according 
to both the humidity and temperature from the environment. With a temperature of 15 - 
35°C and a relative humidity of 85%, most of the eggs become infective after 2 to 5 weeks 
(Glickman et al., 1979; Despommier, 2003). However, with temperatures above 35 °C the egg 
become inactivated, but if the temperature is below 15 °C, the larval development is slow, 
but not destroyed (O'Lorcain, 1995). Most of the reviewed literature considers that a 
Toxocara egg become infective when it contain the second larval stage. Nevertheless, some 
authors have reported that two changes occur inside the egg and, therefore, the infective 
phase would be the third larval stage (Araujo, 1972; Minvielle et al., 1999). 
Dogs and cats become infected with Toxocara by either ingesting infective eggs, ingesting 
tissues from paratenic hosts containing larvae, by transplacental migration of larvae to the 
developing puppies, by transmamary passage of larvae through the milk in young puppies, 
or by ingesting immature adults stages present in the vomit or feces of infected puppies 
(Minvielle et al., 1999; Despommier, 2003). 
When infective Toxocara eggs are ingested by puppies, the larvae are released in the small 
intestine and invade the intestinal mucosa, enter the lymphatic or blood vessels and reach 
the liver within 24 to 48 hours. Through the bloodstream, the larvae reach the heart and 
lungs, arrive to the alveolar capillaries and then ascend the respiratory tree to reach the 
pharynx, where they are swallowed. During the migration, the larvae undergo two changes 
of their body and finally complete the development process to the adult stage in the small 
intestine. Egg production occurs between 4 and 6 weeks postinfection (Despommier, 2003). 
Interestingly, this process do not occurs in dogs older than 6 months because the migrant 
larvae do not follow the tracheal route and penetrate into the pulmonary veins and are 
distributed in almost all the body by means of the systemic circulation, especially in the 
lungs, liver, kidney, skeletal muscles, but also in the brain. This distribution is known as 
somatic migration where the parasite is restricted to the larval stage and remains dormant 
for years (Glickman & Schantz, 1983; Overgaauw, 1997). 
Toxocara eggs can also be infective for a number of other species different from canines or 
felines, a phenomenon known as ‘paratenesis’ (passage of the infective parasite by one or 
various hosts with no effect on the completion of its life cycle). Paratenic hosts for 
toxocariasis include earthworms, mice, rats, rabbits, chickens, pigs, pigeons, sheep, and 
humans. As the larvae remain alive in the paratenic host for years, a predator may become 
infected when ingest this parasitized tissues. If a predator is a canine or feline, the larvae 
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complete their development in the alimentary tract, but it depends of the age (Minvielle et 
al., 1999; Magnaval et al., 2001; Despommier, 2003). 
Parasitized puppies are the main reservoir of Toxocara. The contamination level produced by 
a female dog and her parasitized puppies in the immediate area of their habitat is very high. 
If we consider that adult stages of Toxocara have an average life of 4 months and each female 
worm produce about 200,000 eggs per day, and the intestinal worm charge may range from 
one to hundreds of them, therefore, infected puppies may contaminate the environment 
with millions of eggs each day (Minvielle et al., 1999; Despommier, 2003). 
Humans become infected by accidental ingestion of embryonated Toxocara eggs containing 
the infective third larval stage. The larvae are released in the proximal small intestine, 
penetrate the mucosa and, through the blood vessels, they reach the portal vein and then, 
they may migrates through the systemic circulation. The larvae are distributed throughout 
the body causing hemorrhages, inflammatory process and granulomas. Many larvae seem to 
remain 'dormant' for many years and then continue their migration. Eventually some of 
them may be destroyed by the host immune response, while others seem to be protected by 
encapsulating them (Magnaval et al., 2001; Despommier, 2003). 
A large proportion of Toxocara infections are either asymptomatic or have nonspecific 
symptoms. The most frequently involved organs are liver, lungs, brain, eyes, heart, and 
skeletal muscles. Clinically, the chronic forms of human toxocariasis may be widespread or 
localized; being the latter the most common and it can also lead to blindness (Pawlowski, 
2001; Despommier, 2003). 
The clinical manifestations may be divided into an acute phase (usually uncertain and 
unspecified) and a chronic phase. The acute phase of infection takes place immediately after 
the larvae penetrate the intestinal epithelium and reach the blood vessels and through them, 
migrate to the liver, which is the first organ to be affected. The inflammatory response 
degree of the live will depend on the number of migrating larvae to be ingested by the host, 
because a small number of larvae can be achieved unnoticed into the portal vein without 
producing signs. From there, the larvae can travel to other organs like heart, lungs, and 
kidney, starting the chronic phase of the infection. This migration may also include 
immunologically privileged organs such as the eye and brain (Pawlowski, 2001; Smith et al., 
2009). Larval migration may generates nonspecific symptoms such as myalgia, fever, 
malaise, and may cause wheezing and airway hyperresponsiveness, especially in children or 
predisposed people. 
The spectrum of clinical manifestations in human toxocariasis varies widely from 
asymptomatic cases to systemic forms of the disease; probably due to the size of inoculum 
and the host response against the migrating larvae (Taylor et al., 1988, Pawlovski, 2001). 
During the larval migration, the larva releases a high content of metabolic antigens that 
leads to the activation of the host immune system which generates an immunopathogenic 
mechanism that causes the clinical manifestations of the disease. The immune response 
against the parasite is mediated in different proportions of either T-helper 1 (Th1) cells 
(which leads to a granuloma formation) and T-helper 2 (Th2) cells (an increased production 
of IgE antibodies and eosinophils) (Sugane & Oshima, 1984; Kayes, 1997; Pawlovski, 2001). 
In this point, allergic, atopic or eosinophil-related manifestations may occur and depend on 
the type of response of each Toxocara infected host. 
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3. Clinical manifestations of human toxocariasis 
Several clinical forms of human toxocariasis have been described, but until moment, few 
attempts were made to classify the clinical expressions derived from Toxocara infections. A 
proposed classification made by Pawlovski (2001) correlate the observed clinical status, the 
involvement of immunopathologic mechanisms, the intensity of the serological response, 
and the location of Toxocara larvae. This new classification divides human toxocariasis into 
four major forms namely: systemic, compartmentalized, covert and asymptomatic. 
However, Smith et al. (2009) still consider that human toxocariasis should be classified in 
three major forms: visceral larva migrans, ocular toxocariasis, and covert toxocariasis. 
Visceral larva migrans, described by Beaver et al. (1952), is a severe systemic form of 
toxocariasis which is characterized by high eosinophilia, hepatosplenomegaly, pulmonary 
involvement, fever, hypergammaglobulinaemia, and elevated isohemagglutinins. Cases of 
LMV are uncommon and occur almost exclusively in children (Schantz & Glickman, 1978; 
Magnaval et al., 2001; Despommier, 2003). However, this syndrome may be restricted to 
clinically much less severe cases, in which only some signs of the classic visceral larva 
migrans form may occur, such as hepatomegaly and eosinophilia (Pawlovski, 2001). Many 
times the chronic eosinophilia is the main reason to suspect of toxocariasis (Magnaval et al., 
2001; Pawlovski, 2001; Despommier, 2003). Hepatomegaly, fever and abdominal pain may 
be found when the compromise is exclusively hepatic (Magnaval et al., 2001). Dry cough, 
wheezing, bronchospasm, interstitial pneumonitis, and pleural effusion may occur when a 
lung involvement is present (Roig et al., 1992; Ashwath et al., 2004). Pruritus and 
eosinophilic urticaria may also present in some patients with dermatological manifestations 
(Kim et al., 2010). Other manifestations also include arthralgia, vasculitis, pericardial 
effusion, etc (Pawlovski, 2001; Despommier, 2003). 
Ocular toxocariasis is a localized form of toxocariasis and is a result of the ocular invasion 
by Toxocara larvae, causing a series of clinical conditions, including endophthalmitis 
(Magnaval et al., 2001; Pawlovski, 2001; Despommier, 2003; Smith et al., 2009), which may 
be confused with a malignant tumor known as retinoblastoma (Minvielle et al., 1999; 
Magnaval et al., 2001; Despommier, 2003). The parasite is located within the ocular globe 
and often causes uveitis and retinal granulomas (Dernouchamps et al., 1990), which is 
confused with other etiologies and which may pass almost unnoticed, since the patient only 
afflicts progressive decrease in visual acuity (Pawlovski, 2001; Despommier, 2003); some 
patients present pain or bleeding due to severe intraocular inflammation (Magnaval et al., 
2001; Despommier, 2003). 
Another localized form of human toxocariasis which has become more important in recent 
years is the neurotoxocariasis, a clinical entity resulting from the invasion of the brain by 
Toxocara larvae (Finsterer & Auer, 2007). In the brain, Toxocara larvae are not encapsulated 
and the traces of their migration generally include small areas of necrosis and minimal 
inflammatory infiltration. Therefore, several cases of neurotoxoxariasis are asymptomatic 
while in others, the symptoms may vary widely. A case-control study on patients with 
Toxocara infection concluded that larval migration in the human brain does not necessarily 
induce neurological symptoms or signs (Magnaval et al., 1997), but some symptoms such as 
neurological deficits, focal seizures, generalized behavioral disorders and eosinophilic 
meningoencephalitis have been reported in different human cases of toxocariasis (Hill et al., 
1985; Skerrett & Holland, 1997). 
www.intechopen.com
 
Immunodiagnosis of Human Toxocariasis 
 
101 
Covert toxocariasis is another form of toxocariasis whose term introduced by Taylor et al. 
(1987), is less well defined and frequently undiagnosed but it can commonly occur. Covert 
toxocariasis is characterized by nonspecific signs and symptoms that do not fall into the 
category of classic visceral larva migrans, ocular toxocariasis or neurotoxocariasis. Covert 
toxocariasis seems to depend less on a local reaction to the Toxocara larvae but is more an 
organ oriented immunopathological host response to continued stimulation of the host 
immune system by parasite antigens (Pawlovski, 2001). The clinical expression varies 
widely and may present as a pulmonary involvement such as asthma, acute bronchitis, 
pulmonitis with or without a Loeffler syndrome (Feldman & Parker, 1992; Buijs et al., 1997; 
Inoue et al., 2002), dermatological disorders such as chronic urticaria or eczema (Wolfrom et 
al., 1995), lymphadenopathy, myositis and a pseudorheumatic syndrome such as arthralgia 
(le Lauyer et al., 1990; Kraus et al., 1995). 
Analysis of the causal relation of Toxocara infection with clinically observed 
symptomatology requires a good clinical knowledge and assessment of laboratory tests 
including the detection of IgG and IgE specific antibodies, eosinophilia and others 
(Magnaval et al., 2001; Despommier, 2003). Covert toxocariasis is often confirmed by 
alleviation or disappearance of specific symptoms and signs after specific anti-helmintic 
treatment (Magnaval et al., 2001; Pawlovski, 2001; Smith et al., 2009). 
Asymptomatic toxocariasis or simply named Toxocara infection is often diagnosed by 
positive serology, occurs mainly in light or old infections and do not require anthelmintic 
treatment (Huapaya et al., 2009; Smith et al., 2009). Some cases may present mild 
eosinophilia, but it do not means a hazard for the patient, however, is important to consider 
this condition, especially in epidemiological studies on this zoonotic disease which are more 
frequent worldwide (Huapaya et al., 2009). 
4. Diagnosis of human toxocariasis 
Humans are considered as paratenic hosts within the life cycle of Toxocara where the larvae 
cannot develop into adult worms and, therefore, the parasitological examination of faeces 
does not contribute to the laboratory diagnosis (Rubinsky-Elefant et al., 2010). The diagnosis 
of toxocariasis is generally based on clinical signs and symptoms, which are non-specific, 
epidemiological data (contact with dogs or cats, geophagia, onychophagy, consumption of 
undercooked or raw meats) and laboratory findings (Chieffi et al., 2009; Despommier, 2003; 
Magnaval et al., 2001; Watthanakulpanich, 2010). 
A definitive diagnosis of human toxocariasis is possible by locating the larvae in infected 
tissues, using histopathological examination. Tissue biopsy is rarely justified and it is 
generally insensitive and a time-consuming method (Pawlowski, 2001; Rubinsky-Elefant et 
al., 2010). Polymerase chain reaction (PCR)-based methods for Toxocara identification in 
clinical and environmental samples have been described (Fogt-Wyrwas et al., 2007; Zhu et 
al., 2001), but are not widely available. These methods should provide useful tools for the 
diagnosis and molecular epidemiological investigations of toxocariasis (Li et al. 2007). 
Parasite antigens can be detected in granulomas by immunohistochemical techniques and 
are helpful for toxocariasis diagnosis (de Brito et al., 1994; Musso et al., 2007). Medical 
imaging techniques such as ultrasonography, computed tomography and magnetic 
resonance imaging have been used to detect granulomatous lesions due to the migration of 
Toxocara larvae in different locations such as liver, nervous system and eye (Degouy et al., 
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2001; Magnaval et al., 2001, Watthanakulpanich, 2010). Toxocara excreted-secreted products 
are highly immunogenic and promote a Th2 type immune response, leading to the 
production of interleukin 4 and 5, and consequently an increase of IgG, IgE antibodies and 
eosinophilia (Kayes et al., 1980; Del Prete, 1991).  In visceral larva migrans, some frequent 
laboratorial findings are leukocytosis with intense eosinophilia, hypergammaglobulinemia 
and isohemagglutinin titer elevation (Jacob et al., 1994). However, in ocular toxocariasis, 
because of larval burden are relatively small, peripheral blood eosinophilia is frequently 
absent (Glickman & Schantz, 1981). 
The diagnosis of ocular toxocariasis is usually based on clinical evaluation with the presence 
of ocular lesions, such as retinal or peripheral granulomas and endophthalmitis. Anti-
Toxocara antibody titers are usually higher in visceral larva migrans than in ocular 
toxocariasis (Elefant et al., 2006). Even low ELISA titres in the serum may be of diagnostic 
value, but there is no consensus about the cut-off titres for diagnosis (Rubinsky-Elefant et 
al., 2010). 
In covert toxocariasis some patients do not present eosinophilia and symptoms are 
unspecific (Magnaval et al., 2001). Detection of anti-Toxocara antibodies in clinically 
suspected toxocariasis patients in different samples, such as serum, ocular or cerebrospinal 
fluid is valuable to establish the diagnosis (Magnaval et al., 2001; Vidal et al., 2003; de Visser 
et al., 2008; Smith et al., 2009;). 
5. Immunoserological techniques for diagnosing human toxocariasis 
The limitations of the parasitological techniques to diagnosing human toxocariasis have 
encouraged numerous researchers to develop practical and accurate immunoassays. Several 
immunodiagnostic tests have been described, such as intradermal reaction,  complement 
fixation, bentonite flocculation, agar-gel diffusion, indirect hemagglutination, 
immunofluorescence, radioimmunoassay and immunoenzymatic assays (Glickman & 
Schantz, 1981). The antigens used in these immunoassays included somatic extracts of adult 
worms, embryonated eggs, intact or sectioned larvae, and metabolic products of larvae 
collected in vitro. 
Nowadays, the excretory-secretory antigens of T. canis larvae (TES) are widely used in 
serodiagnostic tests that are used for both the diagnosis and seroepidemiological studies 
(Roldán et al., 2010). These antigens are obtained from in vitro maintenance of infective larvae 
and are a mixture of highly immunogenic glycoproteins (Maizels et al., 1993). Since the first 
description of TES antigens production (De Savigny, 1975), few modifications in the method 
have been made. Recently, modified protocols for TES antigens production has been reported, 
increasing the parasite yield up to five fold, improving the larval purity and reducing the 
execution time of the protocol (Alcântara-Neves et al., 2008; Ponce-Macotela et al., 2011). 
The use of validated serodiagnostic tests has provided a good understanding on the 
prevalence of human exposure to Toxocara. Toxocariasis is one of the few human parasitic 
diseases whose serodiagnosis uses a standardized antigen (Smith et al., 2009). Currently, the 
best serodiagnostic options are using the ELISA-IgG as a screening test and confirm any 
positive serum with an immunoblot test. In addition, each positive serum may also be 
confirmed by using an ELISA-IgE (Magnaval et al., 2001; Smith et al., 2009), as discussed 
below. 
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5.1 Enzyme-Linked Immunosorbent Assay 
The Enzyme-linked immunosorbent assay (ELISA) test using TES antigens is the most 
common diagnostic method to detect anti-Toxocara IgG antibodies (De Savigny, 1979; 
Magnaval et al., 2001; Elefant et al., 2006; Smith et al., 2009), but it remains problematic in 
areas where the polyparasitism is endemic and the possibility of cross-reactions is high, 
reducing its diagnostic value. False positive results may occur in patients with ascariasis, 
strongyloidosis, trichinellosis, and fasciolosis (Magnaval et al., 2001; Ishida et al., 2003; 
Chieffi et al., 2009; Roldán et al., 2009; Smith et al., 2009). In order to reduce the cross-
reactivity with other parasites, many authors have proposed previous serum absorption 
with extracts of a variety of nonhomologous parasites, i.e. pre-incubating serum samples 
with antigenic extracts of adult stages of Ascaris suum (Camargo et al., 1992; Nunes et al., 
1997; Elefant et al., 2006), while others use a more comprehensive panel of antigen extracts 
from nematodes, cestodes and protozoa (Lynch et al., 1988). 
The human IgG response elicited by Toxocara larvae may persist for many years (Cypess et 
al., 1977; Elefant et al., 2006) and, therefore, a positive result by ELISA-IgG cannot 
distinguish between past and current infection (Roldán et al., 2009). Moreover, high levels of 
anti-Toxocara antibodies may be found in preschool children, in comparison with older 
children or adults living in the same community (Rubinsky-Elefant et al., 2008), suggesting 
that IgG antibody levels tend to decrease when larvae are no longer viable in tissues. 
In human toxocariasis, IgM antibodies are also generated and may be detected in both acute 
and chronic phases, differing from most of unrelated infections, in which they are transient 
(Smith, 1993). 
Other antibody isotypes, such as IgE, may be detected by ELISA and result more specific 
than IgG; however, they are less sensitive for the diagnosis of human toxocariasis 
(Magnaval et al., 1992). In a follow-up of 23 children with visceral toxocariasis, Elefant et al., 
(2006) found that the levels of IgE antibodies were significantly decreased at one year post-
treatment with thiabendazole in comparison with IgG levels which declined only four years 
post-treatment. 
The measurement of the specific IgG avidity by ELISA suggests that it can help in 
distinguishing between acute and chronic infections (Hubner et al., 2001; Dziemian et al., 
2008; Fenow et al., 2008). In the follow-up study after chemotherapy, Elefant et al. (2006) 
found high-avidity IgG antibodies at the time of the diagnosis, without further increase over 
the following years. 
As an alternative to the ELISA, dot-ELISA has been standardized, presenting comparable 
sensitivity of standard ELISA. The advantages of the test are related to stability, lower cost 
and shorter execution time (Camargo et al., 1992; Roldán et al., 2006). 
Regarding to the IgG subclasses, IgG2 and IgG3 antibodies yield sensitivities of 98% and 
78%, respectively (Watthanakulpanich et al., 2008). On the other hand, the detection of IgG4 
antibodies contributes to increase the specificity of the immunoassay (Noordin et al., 2005). 
In ocular toxocariasis cases, probably due to the low number of infective larvae, serum anti-
Toxocara antibodies may be present in very low titres or even undetectable (Sharkey & 
McKay, 1993; Glickman & Schantz, 1981;  Magnaval et al., 2002). However, titers of specific 
antibodies in intraocular fluids, such as vitreous or aqueous humor, are usually higher than 
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those in serum, suggesting a local antibody production (Biglan et al., 1979; De Visser et al., 
2008; Rubinsy-Elefant et al., 2010). 
Because of the cross-reactions occurring in populations from tropical areas, some 
recombinant TES antigens have been expressed and used for the detection of specific IgG 
(Yamasaki et al., 2000; Wickramasinghe et al., 2008; Mohamad et al., 2009) and IgE 
antibodies (Norhaida et al., 2008) with promising results. Two of these recombinant antigens 
named rTES-30 (Yamasaki et al., 2000) and rTES-120 (Fong & Lau., 2004) provide more 
reliable diagnostic results and may be used for the development of serodiagnostic assays for 
human toxocariasis. 
The detection of circulating Toxocara antigens has been reported by a capture enzyme-linked 
immunoassay using monoclonal antibodies (Robertson et al., 1988; Gillespie et al., 1993).  
The assay detects a carbohydrate epitope of TES antigens and proved to be useful in 
confirming acute visceral larva migrans diagnosis. Due to lack of specificity, the test was not 
recommended to be used alone in diagnosis (Gillespie et al., 1993). A monoclonal antibody 
to the TES-120 kDa antigen has been described and may be useful for determining both the 
parasite burden in early infection and the efficacy of chemotherapy (Yokoi et al., 2002). 
5.2 Immunoblot assay 
The immunoblot or Western blotting assay is a test that combines the high sensitivity of the 
immunoenzymatic tests with the high resolution of sodium dodecyl sulfate-polyacrylamide 
gel electrophoresis (SDS-PAGE). This method has been successfully adapted for the 
confirmatory serodiagnosis of various parasitic diseases, including schistosomiasis, 
hydatidosis, cysticercosis, taeniasis, fasciolosis and strongyloidosis (as described in Roldán 
& Espinoza, 2009). 
Immunoblot assays based on TES antigens have been proposed as confirmatory tests after 
screening by ELISA tests (Magnaval et al. 2001; Roldán & Espinoza, 2009). Two clusters of 
bands have been defined: low molecular weight bands (from 24 to 35 kDa) were reported as 
highly specific, while the high molecular bands (from 132 to 200 kDa) are unspecific 
(Magnaval et al., 1991). Morever, Nunes et al. (1997) found that a band between 55 to 66 kDa 
seems to be the responsible for the cross-reactivity between T. canis and A. suum. 
An immunoblot was standardized for monitoring IgG, IgE and IgA antibodies after-
chemotherapy in patients with toxocariasis. IgG antibodies to >205 kDa fractions, IgA to 29–
38, 48–54, 81–93 kDa and IgE to 95–121 kDa were suggested as candidates for monitoring 
the treatment. Further identification of antigen epitopes related to these markers will allow 
the development of sensitive and specific immunoassays for the diagnosis and therapeutic 
assessment of toxocariasis (Rubinsky-Elefant et al., 2011). 
Nowadays, Immunoblot assay is useful to confirm any positive serum by the ELISA test 
(where pre-absorption is not carried out) in patients with suspected toxocariasis (Magnaval 
et al., 1991; Roldán & Espinoza, 2009; Rubinsky-Elefant et al., 2011). 
In order to give an idea of how to develop an immunoblot assay using TES antigens to 
detect specific IgG antibodies, we describe a protocol developed by Roldán & Espinoza 
(2009), however, we recommend to revise in detail other procedures described by other 
authors (Magnaval et al., 1991; Nunes et al., 1997; Rubinsky-Elefant et al., 2011). 
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The TES antigens may be obtained by in vitro maintaining larval stages of T. canis in RPMI 
1640 cell culture medium supplemented with HEPES and glutamine, as described by 
Bowman et al. (1987). However, it is important to mention that some authors also use the 
traditional method described by De Savigny (1975), which uses Eagle’s minimal essential 
medium supplemented with HEPES and glutamine (Nunes et al., 1997; Elefant et al., 
2006). As a consequence of cultivating the parasite in different kind of culture media, it 
may generate different antigenic bands at the time of separating the TES antigens by SDS-
PAGE.  
The TES antigens should be diluted to a final concentration of 200 μg/mL with sample 
buffer (2.5 mM Tris-HCl, pH 8.0, containing 1% SDS, 50 mM dithiothreitol, 0.4% glycerol 
and 0.025% bromophenol blue), and then heated at 65°C for 15 min, as recommended by 
Tsang et al. (1991). In this part, it is important to mention that other authors use Laemmli’s 
sample buffer to dilute the TES antigens. 
The TES antigens are separated by SDS-PAGE at a constant voltage of 100V for 15 min (to 
move the proteins through the stacking gel) and then at 200V (to move the proteins through 
the resolving gel), until the bromophenol blue reach the end of the gel. Many authors 
usually have used 10% or 12% resolving polyacrylamide gels (Magnaval et al., 1991; Elefant 
et al., 2006), but others prefer use gradient resolving gels, such as 5-15% (Nunes et al., 1997; 
Rubinsky-Elefant et al., 2011) or 4-16% (Roldán & Espinoza, 2009). The relative molecular 
weight (MW) of the TES antigens may be calculated by using the wide-range molecular 
weight markers that are commercially available. 
The separated TES antigens may be transferred to nitrocellulose sheets (0.2 μm pore size) 
using an electrotransfer blotting apparatus with a constant current of 2.0 A or a constant 
voltage of 100V. The time of blotting depends on the model of apparatus and it is very 
important to follow the instructions described in the manual of each apparatus. 
The nitrocellulose sheets containing the TES antigens should be washed for 30 min with 0.01 
M phosphate-buffered saline containing 0.3% Tween 20 (PBS-T), and then cut into 3-mm-
wide strips and stored at -20°C until use. 
These nitrocellulose strips may be incubated with human serum samples diluted at 1:50 in 
PBS-T containing 5% non-fat milk for 2 hours at room temperature or overnight at 4°C. After 
this period of incubation, the strips must be washed 3 times for 5 min each with PBS-T and 
then, the strips must be incubated for 2 hours with an anti-human IgG horseradish 
peroxidase conjugate diluted 1:1000 in PBS-T. After washing 3 times with PBS-T as above, 
the strips must be incubated with a freshly prepared substrate solution (15 mg of 3,3' -
diaminobenzidine tetrahydrochloride, 30 mL of PBS and 10 μL of 30% hydrogen peroxide). 
After 5 minutes of incubation, the enzymatic reaction must be stopped by washing the strip 
with tap water. Positive reactions on the strip are determined by the visualization of defined 
brown bands judged using the naked eye. 
Usually, a total of 9 antigenic bands (24, 28, 30, 35, 56, 67, 117, 136, y 152 kDa) may be 
detected using this procedure, but the diagnostics bands for the confirmatory 
serodiagnosis of human toxocariasis are the low molecular weight bands (from 24 to 35 
kDa) (figure 1). 
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Fig. 1. An immunoblot strip showing the 9 antigenic bands used for the confirmatory 
serodiagnosis of human toxocariasis. 
6. Final considerations 
Traditional parasitological diagnostic approaches in toxocariasis, regarding the 
identification of the larvae, have innumerous limitations. Therefore, laboratory tests are very 
important to help the clinicians may give a reliable diagnosis. Human toxocariasis has been 
widely investigated, but many questions about to the diagnosis, effectiveness of 
chemotherapy, and prognosis remains to be elucidated. 
Undoubtedly, the use of the TES antigens in ELISA tests has contributed to improve the 
immunodiagnosis and to carry out several epidemiological surveys. However, the levels of 
serum IgG antibodies may remain present for a long time, even in the absence of the disease. 
When using native unfractionated TES, the probability of cross-reactions may occur in 
regions where polyparasitism is endemic. In some ocular toxocariasis cases, the serum 
sample may be repeatable negative without excluding the infection (Smith et al, 2009). 
There are some factors that can influence the diagnostic efficiency, such as variation in 
methods among laboratories, lack of universal units for expressing titers, disagreement in 
the definition of cut-off lines, differences among surveyed populations and interference of 
unrelated diseases, such as asthma, in the reactivity of anti-Toxocara antibodies (Smith et al. 
2009). 
Until moment, the ELISA assay is the most widely accepted serodiagnostic test for the 
detection of anti-Toxocara IgG antibodies. Although the ELISA may detect infections by both 
T. canis and T. cati (Hotez & Wilkins, 2009), the relative contribution of T. cati as etiologic 
agent of toxocariasis cases has been underestimated (Fisher, 2003). A development of a T. 
cati recombinant antigen would be useful for a better understanding on T. cati infection 
(Smith et al., 2009). 
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There are many points to be improved in the immunodiagnosis of human toxocariasis, such 
as the establishment of a standard cut-off value, the definition of true toxocariasis cases and 
true negative samples. 
To establish the final diagnosis of visceral or ocular toxocariasis, clinical signs, symptoms, 
laboratory data and eosinophil count should be considered (Roldán et al., 2010; Rubinsky-
Elefant et al., 2010). On the other hand, the definition of the true negative cases is also 
complicated and it should be taken in account at the moment of calculating the cut-off 
values. A positive result in a serological test does not necessarily indicate a causative 
relationship between Toxocara infection and current disease (Pawlowski, 2001). Moreover, in 
developing countries with a high prevalence of soil-helminth zoonoses is difficult to find 
true negative serum samples to be used as controls in immunoassays for toxocariasis. 
Further studies are crucial to improve the sensitivity and specificity of the immunoassays 
for toxocariasis in order to determine the course of the disease.  Tools for distinguish 
between current or past infection, to improve the diagnosis of ocular toxocariasis, and to 
define the effectiveness of the therapeutics are needed. Probably, a mixture of recombinant 
antigens will improve the efficacy of the immunoassays (Mohamad et al., 2009). 
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